English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2189]
News [5845]
Articles [114]
Editorials [31]
Conferences [184]
elearning [22]
Magnetosome-like structure with high tumour tissue penetration efficiency constructed
Magnetosome-like structure with high tumour tissue penetration efficiency constructed
Restoring the gut biome after antibiotics could lead to better outcomes for ovarian cancer patients
Restoring the gut biome after antibiotics could lead to better outcomes for ovarian cancer patients
NCCN working with Medlive to advance high-quality cancer care in China and worldwide
NCCN working with Medlive to advance high-quality cancer care in China and worldwide
Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence
Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence
Scientists look for microscopic clues to beating deadly brain tumors
Scientists look for microscopic clues to beating deadly brain tumors
On the trail of missing genes and cancer clues
On the trail of missing genes and cancer clues
Advanced nanoparticles provide new weapon to fight difficult cancers
Advanced nanoparticles provide new weapon to fight difficult cancers
US NIH report: Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer
US NIH report: Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer
Researchers identify specific alterations in the BRAF gene that may affect response to treatment and survival in adult brain cancers
Researchers identify specific alterations in the BRAF gene that may affect response to treatment and survival in...
Response-adapted ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B-cell lymphomas
Response-adapted ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B...
<1...9596979899...585>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top